spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  testosterone deficiency 

 HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2014
Clarus Therapeutics Secures $31.5 Million in Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 May 2014
Clarus Therapeutics Appoints Patrick Shea Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2014
Clarus Therapeutics Appoints John Gargiulo Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2014
U.S. FDA Approves AVEED(TM) (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jul 2007
Repros Reports That Patients Exposed to Proellex For Up To Six Months Demonstrated A Benign Endometrium Based On Biopsy
Biopharmaceuticals
 HSMN NewsFeed - 5 Jul 2007
Peer Reviewed Journal Article Indicates Repros' Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2007
CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of Becocalcidiol
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 20 Dec 2006
Repros' Androxal Shows Noninferiority in Interim Phase 3 Analysis
Biopharmaceuticals
 HSMN NewsFeed - 18 Dec 2006
Repros Announces Appointment of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2006
Repros Reports Proellex Achieves Statistically Significant Pain Reduction in Endometriosis Trial
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2006
Repros Reports Partial Interim Assessment of Phase 2 Study of Proellex(TM) in Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2006
Repros Therapeutics Provides Update for Ongoing Clinical Studies
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 24

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 24 additional stories matching:
testosterone deficiency
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.